Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no increase in ISTH major bleeding risk. Detailed data from the trial will be presented at an upcoming scientific congress. 1

In 119 patients who came to emergency departments on average about 12 hours after stroke onset - for whom there was no approved drug treatment - scp776 resulted in clinically meaningful improvements in outcomes compared to a placebo, researchers reported at the 2025 World Stroke Congress in Barcelona.

A patient with blink-triggered visual tilt shows a cortical lesion that initially mimicked a peripheral vestibular disorder.

When someone walks into an emergency room with symptoms of a stroke, every second matters. But today, diagnosing the type of stroke, the life-or-death distinction between a clot and a bleed, requires large,

Topline data show the Factor XIa inhibitor asundexian lowers recurrent stroke risk vs placebo with no increase in major bleeding events.

We are definitely seeing more young people coming in with strokes,” says Dr. Joshua Willey, a stroke neurologist at NewYork-Presbyterian/Columbia University Irving Medical Center (who didn’t treat Glover).

Foster has been truly impressed, and made more progress in 6 months with the PoNS device than in 4 years of traditional therapy.

The Ballina native, David O’Donnell, defied medical odds to rebuild his life following a stroke at the age of two and is dedicating his future to supporting fellow survivors across Ireland.

"They found a hole in my heart," the singer and actor revealed of the 2024 health issues that forced him to cancel his "New World Tour."

Life-threatening strokes are in the spotlight. A neurologist explains the symptoms, treatment, and vital prevention steps.